Pfizer has reported an out of stock for Epanutin 50mg Infatabs until November 2019. To help mitigate the shortage, Pfizer has obtained approval from the Medicines and Healthcare Products Regulatory Agency (MHRA) to import stock of Dilantin 50mg Infatabs (phenytoin base) from Canada. Download additional information.
The company also advises that there may be clinically relevant differences between the two products. Any switches to different presentations must be managed under medical supervision and monitoring of phenytoin serum levels to ensure the correct dosage is being given.
This information has also been added to the Clinical Zone, where information on supply shortages is now being collated for members’ convenience